AB SCIEX expands presence in India
AB SCIEX has announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt. Ltd. The acquisition marks AB SCIEX?s increasing investment in India, combining their global resources with well established local expertise. They have been actively involved in applying the potential of mass spectrometry to assist in protecting the health and safety of India?s population.
AB SCIEX has announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt. Ltd. The acquisition marks AB SCIEX’s increasing investment in India, combining their global resources with well established local expertise. They have been actively involved in applying the potential of mass spectrometry to assist in protecting the health and safety of India’s population.
The transition of Labindia’s mass spectrometry business, including customer relationships, personnel and application support facilities, to AB SCIEX is due to the successful partnership they have nurtured over the past 15 years. The expansion of its commercial operations in India will create new opportunities for customer interactions, collaborations and innovation.
Umesh Pawa, Managing Director, AB SCIEX India, said, “Expansion of AB SCIEX’s commercial operations in India will strengthen our position and help us build on the success of Labindia’s mass spectrometry business as well as execute on our growth strategy. By integrating Indian sales, service and support functions into AB SCIEX's global resources and operational excellence, we will simplify the process for customers to do business with AB SCIEX and drive the highest standard of support, further enhancing customer satisfaction levels. We will now be able to engage in a new level of dialogue with Indian scientists, who are among the leaders pushing the limits to improve life in this region.”
AB SCIEX and Labindia are working very closely to ensure that the transition goes as smoothly as possible.
For more information please visit ref="http://www.absciex.com/india">www.absciex.com/india
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
